FDA Inspection 1291278 — Gojo Industries

Gojo Industries — FEI 3011493299

The FDA completed an inspection of Gojo Industries on November 7, 2025 in Wooster, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 7, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wooster, OH (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
192021 CFR 211.166(a)(3)Valid stability test methods
360321 CFR 211.160(b)Scientifically sound laboratory controls